CUTTING EDGE TECHNOLOGY TO BIOPRINT MINI-KIDNEYS!
Using 3D bioprinting technology, the researchers produced miniature human kidneys in the lab. The study includes biotech company Organovo, Murdoch Children's Research Institute (MCRI).
The research team also validated the use of 3D bioprinted human mini-kidneys to screen for drug toxicity from a class of drugs known to cause kidney damage in humans. The study demonstrated how 3-D bioprinting of stem cells would produce sheets of kidney tissue large enough for transplants.
Artificial living tissue was produced using extrusion-based 3D bioprinting technology and bioink consisting of stem cells.
Melissa Little, who started growing kidney organoids in 2015, stated that the 3D bioprinting method allows a faster and more reliable process. The study found that with 3D bioprinting, it was able to create about 200 mini-kidneys in 10 minutes without sacrificing quality.
The mini-kidneys produced resemble a normal-sized kidney. Using mini-organs, drugs will be screened to find new treatments for kidney disease. It will also be tested whether a new drug is likely to damage the kidney. The toxicity of aminoglycosides, a class of kidney-damaging antibiotics, was also tested in this study. Professor Little stated that they found that the death of certain cell types increased in kidneys treated with aminoglycosides.
REFERENCES
Cutting edge technology to bioprint mini-kidneys
Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation
Derek Arndt
Stephen Pentoney
Sharon C. Presnell
Alice E. Chen
Comments
Post a Comment